Protherics matches expectations in first half
This article was originally published in Scrip
Executive Summary
Protherics' first half was in line with expectations as revenues increased and the net loss reduced. The encouraging results will strengthen the value of the overall company when it merges with BTG next month to create a specialty pharmaceuticals business (Scrip Online, November 13th, 2008).